S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Bank Accounts: Frozen! (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Bank Accounts: Frozen! (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Bank Accounts: Frozen! (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Bank Accounts: Frozen! (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Niinistö: Sweden security OK if Finland joins NATO first
The End of Coca Cola's Compressed Margins
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
Which Gold Stocks Can Help You Hedge Bank Exposure?
Enphase Energy is Still a Buy for Long-Term Growth Investors
NASDAQ:ACCD

Accolade - ACCD Stock Forecast, Price & News

$11.96
-0.31 (-2.53%)
(As of 03/17/2023 08:53 PM ET)
Add
Compare
Today's Range
$11.76
$12.41
50-Day Range
$7.74
$13.30
52-Week Range
$4.61
$19.39
Volume
685,300 shs
Average Volume
726,425 shs
Market Capitalization
$870.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.25

Accolade MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
10.8% Upside
$13.25 Price Target
Short Interest
Healthy
4.30% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.70
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$15,838 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($6.49) to ($2.07) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.40 out of 5 stars

Business Services Sector

106th out of 318 stocks

Business Services, Not Elsewhere Classified Industry

38th out of 93 stocks


ACCD stock logo

About Accolade (NASDAQ:ACCD) Stock

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Receive ACCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accolade and its competitors with MarketBeat's FREE daily newsletter.

ACCD Stock News Headlines

Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Michael Hilton Joins Accolade Board of Directors
Why Shares of Accolade Soared This Week
Bank Accounts: Frozen!
In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!
Accolade's Return On Capital Employed Overview
BTIG Keeps Their Hold Rating on Accolade (ACCD)
Accolade, Inc. (ACCD) Q2 2023 Earnings Call Transcript
See More Headlines
Receive ACCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Accolade and its competitors with MarketBeat's FREE daily newsletter.

ACCD Company Calendar

Last Earnings
1/09/2023
Today
3/20/2023
Next Earnings (Estimated)
4/27/2023
Fiscal Year End
2/29/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:ACCD
Fax
N/A
Employees
2,350
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$13.25
High Stock Price Forecast
$16.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+10.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
16 Analysts

Profitability

Net Income
$-123,120,000.00
Net Margins
-129.59%
Pretax Margin
-129.51%

Debt

Sales & Book Value

Annual Sales
$357.87 million
Book Value
$12.78 per share

Miscellaneous

Free Float
67,474,000
Market Cap
$870.53 million
Optionable
Not Optionable
Beta
1.62

Key Executives

  • Mr. Rajeev Singh (Age 55)
    Chairman & CEO
    Comp: $847.24k
  • Mr. Robert Cavanaugh (Age 54)
    Pres
    Comp: $644.93k
  • Mr. Stephen H. Barnes CPA (Age 51)
    CFO & Treasurer
    Comp: $602.66k
  • Mr. Michael W. Hilton (Age 58)
    Chief Innovation Officer
    Comp: $598.39k
  • Mr. Todd Friedman
    Sr. VP of Investor Relations
  • Mr. Richard Eskew
    EVP, Gen. Counsel, CCO & Sec.
  • Ms. Carolina Lobo
    Chief Marketing Officer
  • Ms. Kristen Keating Weeks
    Sr. VP of Strategy, Corp. Devel. & Partnerships
  • Ms. Jennifer Hanson
    Exec. VP of People and Culture & Chief HR Officer
  • Mr. Todd Clardy
    Exec. VP & GM of Mid-Market Bus.













ACCD Stock - Frequently Asked Questions

Should I buy or sell Accolade stock right now?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Accolade in the last year. There are currently 8 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ACCD shares.
View ACCD analyst ratings
or view top-rated stocks.

What is Accolade's stock price forecast for 2023?

16 Wall Street research analysts have issued 1 year price targets for Accolade's stock. Their ACCD share price forecasts range from $9.00 to $16.00. On average, they anticipate the company's share price to reach $13.25 in the next year. This suggests a possible upside of 10.8% from the stock's current price.
View analysts price targets for ACCD
or view top-rated stocks among Wall Street analysts.

How have ACCD shares performed in 2023?

Accolade's stock was trading at $7.79 at the beginning of the year. Since then, ACCD shares have increased by 53.5% and is now trading at $11.96.
View the best growth stocks for 2023 here
.

When is Accolade's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our ACCD earnings forecast
.

How were Accolade's earnings last quarter?

Accolade, Inc. (NASDAQ:ACCD) released its earnings results on Monday, January, 9th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.61) by $0.05. The firm had revenue of $90.95 million for the quarter, compared to the consensus estimate of $87.53 million. Accolade had a negative trailing twelve-month return on equity of 28.47% and a negative net margin of 129.59%. The company's revenue was up 9.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.31 earnings per share.

What ETFs hold Accolade's stock?
What guidance has Accolade issued on next quarter's earnings?

Accolade issued an update on its fourth quarter 2023 earnings guidance on Monday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $97.00 million-$101.00 million, compared to the consensus revenue estimate of $101.71 million.

What is Rajeev Singh's approval rating as Accolade's CEO?

152 employees have rated Accolade Chief Executive Officer Rajeev Singh on Glassdoor.com. Rajeev Singh has an approval rating of 74% among the company's employees.

What other stocks do shareholders of Accolade own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Accolade investors own include Honeywell International (HON), CVS Health (CVS), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), Alibaba Group (BABA), Home Depot (HD), Procter & Gamble (PG), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO) and Intel (INTC).

When did Accolade IPO?

(ACCD) raised $176 million in an IPO on Thursday, July 2nd 2020. The company issued 8,800,000 shares at $19.00-$21.00 per share. Goldman Sachs, Morgan Stanley and BofA Securities served as the underwriters for the IPO and Piper Sandler, Credit Suisse, William Blair, Baird and SVB Leerink were co-managers.

What is Accolade's stock symbol?

Accolade trades on the NASDAQ under the ticker symbol "ACCD."

Who are Accolade's major shareholders?

Accolade's stock is owned by many different institutional and retail investors. Top institutional investors include ARK Investment Management LLC (7.50%), Brown Advisory Inc. (6.93%), Geode Capital Management LLC (1.70%), Millennium Management LLC (1.51%), Bank of America Corp DE (1.09%) and Sumitomo Mitsui Trust Holdings Inc. (1.08%). Insiders that own company stock include Michael W Hilton, Rajeev Singh, Robert N Cavanaugh, Stephen H Barnes and Thomas J Neff.
View institutional ownership trends
.

How do I buy shares of Accolade?

Shares of ACCD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Accolade's stock price today?

One share of ACCD stock can currently be purchased for approximately $11.96.

How much money does Accolade make?

Accolade (NASDAQ:ACCD) has a market capitalization of $870.53 million and generates $357.87 million in revenue each year. The company earns $-123,120,000.00 in net income (profit) each year or ($6.65) on an earnings per share basis.

How many employees does Accolade have?

The company employs 2,350 workers across the globe.

How can I contact Accolade?

Accolade's mailing address is 660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING PA, 19462. The official website for the company is accolade.com. The company can be reached via phone at 206-926-8100 or via email at ir@accolade.com.

This page (NASDAQ:ACCD) was last updated on 3/20/2023 by MarketBeat.com Staff